An Experience in Administration of EPA-Enriched Nutritional Supplementation (ProSurer<sup>®</sup>) for Lung Cancer Patients with Chemotherapy

DOI Web Site 18 References

Bibliographic Information

Other Title
  • 化学療法を行なった肺癌患者に対するEPA強化栄養剤(プロシュア<sup>®</sup>)の投与経験
  • 症例報告 化学療法を行なった肺癌患者に対するEPA強化栄養剤(プロシュア)の投与経験
  • ショウレイ ホウコク カガク リョウホウ オ オコナッタ ハイガン カンジャ ニ タイスル EPA キョウカ エイヨウザイ(プロシュア)ノ トウヨ ケイケン
  • An Experience in Administration of EPA-Enriched Nutritional Supplementation (ProSurer^|^reg;) for Lung Cancer Patients with Chemotherapy

Search this article

Description

The initial case was a man in his 50s. He received 2 cans a day of ProSure®, while undergoing radiation and chemotherapy with carboplatin and docetaxel for adenocarcinoma in the lung. His body weight rose from 62.4 kg on admission to 63.7 kg before discharge, CRP decreased from 3.08 mg/dl to 0.48 mg/dl, and albumin fell from 3.6 g/dl to 3.5 g/dl. The second case was a man in his 60s. He was diagnosed as having squamous cell carcinoma in the lung and administered with 2 cans a day of ProSure® and antibiotics. One-and-a-half months later, he underwent chemotherapy with carboplatin and S-1 and radiation. His body weight stood at 47.0 kg on admission and 47.2 kg before discharge, CRP dropped from 15.45 mg/dl to 3.26 mg/dl, and albumin was retained at 2.6 g/dl to 2.7g/dl. The administration of ProSure® brought about improvements in the nutritional status and anti-inflammatory effects in the patients with chemotherapy.

Journal

References(18)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top